scandenoside R1
114715-44-5
|
Notoginsenoside R3
87741-76-2
|
Vinaginsenoside R3
156012-92-9
|
LONG R3 IGF-I RECOMBINANT ANALOG
143045-27-6
|
(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-carboxybutanoyl]amino]propanoyl]amino]-4-carboxybutanoyl]amino]-4-carboxybutanoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxypropanoyl]amino]-3-phenylpr
101849-76-7
|
Oxiranecarboxamide, 3-methyl-2-propyl-, (2R-cis)- (9CI)
200356-08-7
|
Oxiranecarboxamide, 3-methyl-2-(1-methylethyl)-, (2R,3R)- (9CI)
200356-10-1
|
R3 IGF-I
139659-92-0
|
4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
1158522-08-7
|
1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
940364-43-2
|
2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
134104-43-1
|
1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
131615-57-1
|
(4-Methyl-tetrahydro-furan-2-yl)-methanol
6906-52-1
|
N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
930439-75-1
|
4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
1018584-77-4
|
1,3-Dichloro-5-methoxy-2,4-dinitrobenzene
50903-09-8
|
tert-Butyl-DL-alanine
1375289-11-4
|
4-amino-N-[2-tert-butyl-1-(tetrahydro-2H-pyran-4-ylmethyl)-1H-benzimidazol-5-yl]-N-ethylbenzenesulfonamide
849349-65-1
|
